Article and Video CATEGORIES
For our 9th video in the GRACE Spanish Lung Cancer Library, Dr. Brian Hunis, Medical Director, Head and Neck Cancer Program, Memorial Cancer Institute, Miami, Florida, joined GRACE to discuss the basics of Lung Cancer for Spanish-speaking patients and caregivers, in this video Dr. Hunis reviews the pros and cons of lung cancer screening.
TRANSCRIPTS - Spanish and English
Los pros y los contras de la detencion del cancer de pulmón
La pesquisa para el cancer de pulmón es relativamente nueva. Un estudio muy grande llamado NSLT o estudio de pesquisa en cancer de pulmón, ha demostrado una reducción de muerte por cancer de pulmón, en pacientes con alto riesgo. Los pacientes con alto riesgo son aquellos con por lo menos una exposición a tabaco por cigarrillo de un paquete diario por lo menos por 30 años para pacientes mayores de 65 años.
Una tomografía computada de baja radiación ha demostrado que se pueden encontrar lesiones pequeñas cuando el cancer de pulmón está en estadios tempranos, por lo cual es curativo.
En pacientes que cumplen con las características del estudio, el pro del poder hacer una pesquisa es que en esos pacientes se mostrar cancer de pulmón en estadios tempranos. Las contras es que a veces esos pacientes se van a tener que someter a biopsias que puede resultar ser innecesarias por lesiones pequeñas que pueden resultar no cancerosas.
Pros and cons of lung cancer screening
Research for lung cancer is relatively new. A big trial, NSLT or national lung screening trial has shown a reduction in death for lung cancer in high-risk patients. High-risk patients are those with a higher tobacco exposure of about one cigarette to one daily pack for 30 years in patients older than 65.
A low radiation computed tomography proved that there are some small signs when lung cancer is in the early stage which indicated that it is curable.
In patients that are suitable for the study, the pros of doing an inquest are to find and diagnose early stage lung cancer. However, the cons are that in these patients a biopsy should be done and it could possibly end up being unnecessary for non-cancerous lesions.
Please feel free to offer comments and raise questions in our
discussion forums.
Forum Discussions
Hi elysianfields and welcome to Grace. I'm sorry to hear about your father's progression.
Unfortunately, lepto remains a difficult area to treat. Recently FDA approved the combo Lazertinib and Amivantamab...
Hello Janine, thank you for your reply.
Do you happen to know whether it's common practice or if it's worth taking lazertinib without amivantamab? From all the articles I've come across...
Hi elysianfields,
That's not a question we can answer. It depends on the individual's health. I've linked the study comparing intravenous vs. IV infusions of the doublet lazertinib and amivantamab...
Recent Comments
That's…